Stock listing
NASDAQ:SCTL Recro Pharma Inc Stock
Follow Recro Pharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:SCTL
$1.10 USD
Close on Apr 8, 2024 · No longer trades
- Lowest – highest close
- $0.30 – $18.82 USDSince Nov 22, 2019 · lowest Nov 15, 2023 · highest Dec 30, 2019
Delisted NASDAQ:SCTL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SCTL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Recro Pharma Inc on 6ix
- Calls
- 3 calls with a replay · 3 with a transcript · latest Mar 1, 2022
Where Recro Pharma Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:REPH · Delisted | NASDAQ | United States | USD |
| NASDAQ:REPHV · Delisted | NASDAQ | United States | USD |
| NASDAQ:SCTL · This page · Delisted | NASDAQ | United States | USD |
Events
| Call | When | Status |
|---|---|---|
| Recro Pharma (REPH) Q4 2021 Earnings Call | Tue, Mar 01, 2022 · 4:30 PM ET | Replay |
| Recro Pharma (REPH) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 4:30 PM ET | Replay |
| Recro Pharma (REPH) Q2 2021 Earnings Call | Mon, Aug 09, 2021 · 4:30 PM ET | Replay |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Karen A. Flynn Other companies: Stevanato Group S.p.A. (Director · Since at least Mar 18, 2026); Sotera Health Company (Director · Since at least Nov 13, 2023); Quanterix Corporation (Director · Since at least Jun 6, 2022); Catalent Inc (Director · Jan 8, 2020 – Oct 27, 2023 · Past); West Pharmaceutical Services, Inc. (Sr VP & Chief Commercial Offic · Jul 1, 2012 – Feb 19, 2019 · Past) | Director · Sep 3, 2015 – Dec 5, 2019 · Past |
| Winston Churchill Other companies: Amkor Technology, Inc. (General Partner, SCP Partners and Chairman, CIP Capital, Inc. · Since at least Nov 24, 2008); Indus Realty Trust Inc (Director · Apr 27, 2009 – May 12, 2015 · Past); Cyalume Technologies Holdings Inc (Chairman of the Board, Director · Jan 7, 2009 – Feb 15, 2015 · Past); Direct Markets Holdings Corp (Director · Oct 27, 2008 – Jul 2, 2012 · Past); Innovative Solutions and Support, Inc. (Director · Oct 1, 2008 – Jan 3, 2023 · Past) | Director · Mar 6, 2014 – Apr 8, 2024 · Past |
| Bryan M Reasons Other companies: Mallinckrodt Inc (EVP & CFO · Since at least Mar 18, 2019); Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Impax Laboratories Inc (Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past) | Director · Mar 3, 2017 – Apr 8, 2024 · Past |
| William Ashton Other companies: Medicus Pharma Ltd. (Director · Since at least Dec 31, 2024); Spectrum Pharmaceuticals Inc (Director · Feb 23, 2018 – Jul 31, 2023 · Past); SELLAS Life Sciences Group, Inc. (Director · Oct 10, 2017 – Oct 10, 2017 · Past) | Director · May 4, 2018 – Apr 8, 2024 · Past |
| Jyrki Mattila Other companies: BioSpecifics Technologies Corp (Director · Mar 15, 2018 – May 22, 2019 · Past); Lipocine Inc. (Chief Business Officer · Jan 5, 2016 – Jan 26, 2017 · Past) | Executive VP, Business Dev. · Aug 21, 2017 – Jan 2, 2018 · Past |
| Abraham Ludomirski Other companies: Vishay Intertechnology, Inc. (Member of the Compensation Committee · Since at least Mar 18, 2010) | Director · Mar 6, 2014 – Nov 3, 2016 · Past |
| Mathew Paul Arens Other companies: Health Catalyst, Inc (Director · Since at least Dec 1, 2025) | Director · Aug 23, 2023 – Apr 8, 2024 · Past |
| Ryan D. Lake Other companies: Lifecore Biomedical, Inc. (Chief Financial Officer · Since at least Sep 3, 2024) | Chief Financial Officer · Jan 2, 2018 – Apr 8, 2024 · Past |
| Donna Nichols | CAO/Controller · Mar 6, 2014 – Jan 18, 2017 · Past |
| Elena Cant | Director · Sep 1, 2022 – Apr 8, 2024 · Past |
Log in to ask 6ix AI your own questions about Recro Pharma Inc.